Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions

The Lancet Oncology

Volumn 9, Issue 6, 2008, Pages 596-599

  Varadhachary, Gauri R ^a   Raber, Martin N ^a   Matamoros, Aurelio ^a   Abbruzzese, James L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; CYTOKERATIN 2; CYTOTOXIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PLATINUM DERIVATIVE; TRANSCRIPTION FACTOR CDX2; VASCULOTROPIN RECEPTOR;

ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; CANCER SCREENING; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE COURSE; DNA MICROARRAY; DRUG RESPONSE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 44249126754     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70151-7     Document Type: Note

References (18)

1. N Pavlidis K Fizazi Cancer of unknown primary (CUP) Crit Rev Oncol Hematol 54 2005 243 250
2. R Bugat A Bataillard T Lesimple Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002) Br J Cancer 89 suppl 1 2003 59 66
3. RW Tothill A Kowalczyk D Rischin An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin Cancer Res 65 2005 4031 4040
4. JD Hainsworth WJ Lennington FA Greco Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site J Clin Oncol 18 2000 632 635
5. A Rashid K Hess R Lenzi MN Raber JL Abbruzzese GR Varadhachary Overexpression and prevalence of molecular markers in patients with cancer of unknown primary (CUP) Proc Am Soc Clin Oncol 23 2005 (abstr 9683).
6. C Erlichman DJ Sargent New treatment options for colorectal cancer N Engl J Med 351 2004 391 392
7. W Blumenfeld GK Turi G Harrison D Latuszynski C Zhang Utility of cytokeratin 7 and 20 subset analysis as an aid in the identification of primary site of origin of malignancy in cytologic specimens Diagn Cytopathol 20 1999 63 66
8. P Chu E Wu LM Weiss Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases Mod Pathol 13 2000 962 972
9. R Moll A Lowe J Laufer WW Franke Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies Am J Pathol 140 1992 427 447
10. T Tot Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma Eur J Cancer 38 2002 758 763
11. M Barbareschi B Murer TV Colby CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs Am J Surg Pathol 27 2003 141 149
12. JL Dennis TR Hvidsten EC Wit Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm Clin Cancer Res 11 2005 3766 3772
13. A Bhattacharjee WG Richards J Staunton Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses Proc Natl Acad Sci USA 98 2001 13790 13795
14. JL Dennis JK Vass EC Wit WN Keith KA Oien Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin Cancer Res 62 2002 5999 6605
15. AI Su JB Welsh LM Sapinoso Molecular classification of human carcinomas by use of gene expression signatures Cancer Res 61 2001 7388 7393
16. D Talantov J Baden T Jatkoe A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin J Mol Diagn 8 2006 320 329
17. AI Kende NJ Carr LH Sobin Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract Histopathology 42 2003 137 140
18. DK McGregor TT Wu A Rashid R Luthra SR Hamilton Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability Am J Surg Pathol 28 2004 712 718